Cynthia Xiuguang Ma MD, PhD

Dr. Ma is a physician scientist with a research focus on pre-clinical and early phase clinical investigations in developing molecular therapeutics for breast cancer through collaborative research. Dr. Ma is leading several investigator-initiated trials with in genomic biomarker focused breast cancer populations, including the neoadjuvant AKT inhibitor trial in the PIK3CA mutant population, the neoadjuvant CDK4/6 inhibitor in the PIK3CA WT population and the trial of neratinib in metastatic HER2 non-amplified but mutant patient population.